Sangyong Jon
Impact in
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.1%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Biosensors and Analytical Detection
Papers in
- Biomaterials 57
- Nanoparticle-Based Drug Delivery 55
-
- Nanoplatforms for cancer theranostics 36
- Co-authors
- Róbert LangerOmid C. FarokhzadYong Yeon JeongMi Kyung YuVaishali BagalkotPhilip W. KantoffSang-Jin ParkYonghyun Lee
- Journals
- Journal of Controlled Release (15 papers)Angewandte Chemie International Edition (12 papers)Biomaterials (11 papers)Theranostics (10 papers)Advanced Healthcare Materials (9 papers)
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Sangyong Jon
213 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Biomaterials 5.6k
- Biomedical Engineering 6.7k
- Pharmaceutical Science 759
- Molecular Biology 7.2k
- Molecular Medicine 443
Countries citing papers authored by Sangyong Jon
This map shows the geographic impact of Sangyong Jon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangyong Jon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangyong Jon more than expected).
Fields of papers citing papers by Sangyong Jon
This network shows the impact of papers produced by Sangyong Jon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangyong Jon. The network helps show where Sangyong Jon may publish in the future.
Co-authors
The 25 scholars most cited alongside Sangyong Jon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 51 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 34 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 51 | |
| 13 | 2018 | 146 | |
| 14 | 2018 | 43 | |
| 15 | 2018 | 54 | |
| 16 | 2017 | 25 | |
| 17 | 2017 | 10 | |
| 18 | 2017 | 127 | |
| 19 | 2017 | 22 | |
| 20 | Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Hit paper breakdown → | 2006 | 1353 |
About Sangyong Jon
Sangyong Jon is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Surfaces, Coatings and Films and Immunology and Allergy, having authored 219 papers that have together received 16.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (55 papers), Advanced biosensing and bioanalysis techniques (43 papers), RNA Interference and Gene Delivery (37 papers), Nanoplatforms for cancer theranostics (36 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Heme Oxygenase-1 and Carbon Monoxide (16 papers), Immunotherapy and Immune Responses (15 papers) and Neonatal Health and Biochemistry (13 papers). The work is most often cited by research in Biomaterials (5.6k citations), Biomedical Engineering (6.7k citations), Pharmaceutical Science (759 citations), Molecular Biology (7.2k citations) and Molecular Medicine (443 citations). Sangyong Jon has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Róbert Langer, Omid C. Farokhzad, Yong Yeon Jeong, Mi Kyung Yu, Vaishali Bagalkot, Philip W. Kantoff, Sang-Jin Park, Yonghyun Lee, Jinho Park and Dongkyu Kim. Their work appears in journals such as Journal of Controlled Release, Angewandte Chemie International Edition, Biomaterials, Theranostics and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.